EMBC

Embecta Corp

6.80

Oct 26 • 3:59 PM ET +0.09 (1.34%)

6.74

Aftermarket • 7:30 PM ET -0.06 (-0.88%)

Healthcare Medical Instruments & Supplies USA Small NASD

Peers: BDX MMED RVP KRMD TNDM ICUI BBNX PODD MNKD SENS

| Held by: VTI IWM IWN CALF VXF FNDA DES SCHA VTWO VFVA

Scroll to Statements

Index	RUT
Market Cap	385.29M
Enterprise Value	1.67B
Income	87.50M
Sales	1.02B
Book/sh	-10.81
Cash/sh	3.85
Dividend Est.	0.25 (3.70%)
Dividend TTM	0.32 (4.71%)
Dividend Ex-Date	Aug 27, 2026
Dividend Gr. 3/5Y	58.74% -
Payout	37.05%
Employees	1850
IPO	Mar 22, 2022

P/E	4.58
Forward P/E	3.86
PEG	-
P/S	0.38
P/B	-
P/C	1.77
P/FCF	2.34
EV/EBITDA	5.16
EV/Sales	1.64
Quick Ratio	1.17
Current Ratio	1.68
Debt/Eq	-
LT Debt/Eq	-
Option/Short	Yes / Yes

EPS (ttm)	1.48
EPS next Y	1.76
EPS next Q	0.29
EPS this Y	-37.76%
EPS next Y	-3.96%
EPS next 5Y	-12.88%
EPS past 3/5Y	-25.52% -
Sales past 3/5Y	-1.47% -0.10%
EPS Y/Y TTM	4.11%
Sales Y/Y TTM	-7.60%
EPS Q/Q	-53.64%
Sales Q/Q	-8.05%
Earnings	Aug 07 BMO
EPS/Sales Surpr.	110.68% 6.75%

Insider Own	8.24%
Insider Trans	2.38%
Inst Own	84.65%
Inst Trans	-16.33%
ROA	7.22%
ROE	-
ROIC	11.83%
Gross Margin	59.63%
Oper. Margin	26.38%
Profit Margin	8.59%
SMA20	10.74%
SMA50	20.53%
SMA200	3.62%
Trades

Shs Outstand	56.66M
Shs Float	51.99M
Short Float	11.21%
Short Ratio	4.56
Short Interest	5.83M
52W High	14.91 -54.39%
52W Low	2.77 145.49%
Volatility	4.15% 4.82%
ATR (14)	0.28
RSI (14)	68.79
Beta	0.80
Rel Volume	0.53
Avg Volume	1.28M
Volume	679,507

Perf Week	9.50%
Perf Month	15.25%
Perf Quarter	89.42%
Perf Half Y	-26.41%
Perf YTD	-42.76%
Perf Year	-52.55%
Perf 3Y	-54.27%
Perf 5Y	-
Perf 10Y	-
Recom	3.20
Target Price	4.00
Prev Close	6.71
Price	6.80
Change %	1.34%

Date	Action	Analyst	Rating Change	Price Target Change
May-06-26	Downgrade	BTIG Research	Buy → Neutral
Apr-10-25	Initiated	Mizuho	Neutral	$15
Dec-02-24	Upgrade	Morgan Stanley	Underweight → Equal-Weight	$13 → $20
Nov-27-24	Upgrade	BTIG Research	Neutral → Buy	$26
Oct-20-23	Initiated	Wolfe Research	Peer Perform
Jan-06-23	Downgrade	Morgan Stanley	Equal-Weight → Underweight	$28
Sep-08-22	Initiated	BTIG Research	Neutral
Aug-01-22	Initiated	Morgan Stanley	Equal-Weight	$33
Jun-21-22	Initiated	BofA Securities	Underperform	$25

Aug-31-26 05:00PM	embecta to Participate in Investor Events (GlobeNewswire)
Aug-13-26 04:24AM	Embecta Corp. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - EMBC (PR Newswire) +7.58%
Aug-11-26 07:07AM	EMBC Investor Announcement: Embecta Sued on behalf of Investors to Recover Losses after Insulin Pen Issues Lead to 57% Stock Drop (PR Newswire)
Aug-10-26 07:00AM	Kaplan Fox Encourages Embecta Corp. (EMBC) Investors with Losses to Contact the Firm Before August 17, 2026 (Newsfile) +12.90%
Aug-07-26 03:00PM	Embecta Corp (EMBC) (Q3 2026) Earnings Call Highlights: Strong Sequential Recovery and Raised ... (GuruFocus.com) +26.29%
06:30AM	Loading…
06:30AM	Embecta Corp. Reports Third Quarter Fiscal 2026 Financial Results (GlobeNewswire)
06:00AM	embecta Announces Quarterly Cash Dividend (GlobeNewswire)
Jul-27-26 07:30PM	Kaplan Fox Urges Investors of Embecta Corp. (EMBC) with Significant Losses to Seek a Leadership Role Before August 17, 2026 (Newsfile)
04:40AM	Embecta Corp. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - EMBC (PR Newswire)
Jul-23-26 05:00PM	embecta to Report Fiscal Third Quarter Financial Results (GlobeNewswire)
Jul-21-26 08:30AM	Kaplan Fox Encourages Investors of Embecta Corp. (EMBC) Who Suffered Losses to Contact the Firm Before August 17, 2026 (Newsfile)
Jun-25-26 05:23AM	Embecta Corp. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - EMBC (PR Newswire)
Jun-18-26 10:36AM	Embecta Corp. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights EMBC (Business Wire)
Jun-16-26 06:30AM	embecta appoints Nimish Muzumdar as SVP and President, North America (GlobeNewswire)
Jun-05-26 07:25PM	Marvell Technology and Flex Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600 (PR Newswire)
05:00PM	Loading…
Jun-01-26 05:00PM	embecta to Participate in Investor Events (GlobeNewswire) +6.08%
May-21-26 08:20PM	Levi & Korsinsky Investigating Whether Embecta Corp. (EMBC) Misled Investors - Securities Law Violations Possible (Newsfile) +8.50%
May-18-26 07:13AM	Embecta acquires Owen Mumford for $172.6m (Medical Device Network)
07:10AM	Embecta closes Owen Mumford acquisition for up to $201M (MedTech Dive)
May-15-26 09:00AM	embecta Completes Acquisition of Owen Mumford Holdings Limited (GlobeNewswire)
May-08-26 09:00AM	embecta to Participate at the 2026 BofA Securities Global Health Care Conference (GlobeNewswire)
May-05-26 06:30AM	Embecta Corp. Reports Second Quarter Fiscal 2026 Financial Results (GlobeNewswire) -57.84%
06:30AM	embecta Announces Quarterly Cash Dividend (GlobeNewswire)
Apr-21-26 05:00PM	embecta to Report Fiscal Second Quarter Financial Results (GlobeNewswire)
Mar-20-26 06:35AM	Embecta agrees to acquire Owen Mumford (Medical Device Network)
Mar-19-26 10:37AM	Embecta to buy Owen Mumford for up to $201M (MedTech Dive)
06:30AM	embecta Announces Definitive Agreement to Acquire Owen Mumford Holdings Limited (GlobeNewswire)
Feb-11-26 04:10PM	embecta names new Chairman of the Board and Lead Independent Director (GlobeNewswire)
Feb-05-26 05:30PM	Embecta Q1 Earnings Call Highlights (MarketBeat) -7.75%
02:02PM	Embecta Corp (EMBC) Q1 2026 Earnings Call Highlights: Strategic Progress Amidst Market Challenges (GuruFocus.com)
06:30AM	Loading…
06:30AM	Embecta Corp. Reports First Quarter Fiscal 2026 Financial Results (GlobeNewswire)
06:00AM	embecta Announces Quarterly Cash Dividend (GlobeNewswire)
Jan-22-26 05:00PM	embecta to Report Fiscal First Quarter Financial Results (GlobeNewswire) -9.44%
Dec-18-25 05:00PM	embecta to Participate at the J.P. Morgan 2026 Healthcare Conference (GlobeNewswire)
Nov-25-25 02:01PM	Embecta Corp (EMBC) Q4 2025 Earnings Call Highlights: Strategic Advances Amid Revenue Challenges (GuruFocus.com) -7.24%
06:30AM	Embecta Corp. Reports Fiscal 2025 Fourth Quarter and Full Year Financial Results; Provides Initial Fiscal Year 2026 Financial Guidance (GlobeNewswire)
06:00AM	embecta Announces Quarterly Cash Dividend (GlobeNewswire)
Nov-20-25 07:50AM	EMBC Q4 Preview: Product Momentum and Strategy Gains to Support Growth? (Zacks)
Nov-17-25 05:00PM	embecta announces changes to Board of Directors (GlobeNewswire)
Nov-14-25 06:30AM	embecta Announces Major New Commitment to Direct Relief on World Diabetes Day (GlobeNewswire)
Nov-11-25 05:00PM	embecta to Report Fiscal Fourth Quarter and Full Year 2025 Financial Results (GlobeNewswire)
Oct-06-25 05:15AM	Best Value Stocks to Buy for October 6th (Zacks)
Sep-15-25 08:06AM	Best Income Stocks to Buy for September 15th (Zacks)
05:37AM	New Strong Buy Stocks for September 15th (Zacks)
Sep-09-25 04:12AM	Best Value Stocks to Buy for September 9th (Zacks)
Aug-26-25 05:00PM	embecta to Participate in Investor Events (GlobeNewswire)
Aug-25-25 09:30AM	Embecta Corp. (EMBC) Crossed Above the 200-Day Moving Average: What That Means for Investors (Zacks)
Aug-12-25 09:55AM	Wall Street Analysts Predict a 25.69% Upside in Embecta Corp. (EMBC): Here's What You Should Know (Zacks)
Aug-09-25 03:03AM	Embecta Corp (EMBC) Q3 2025 Earnings Call Highlights: Record Revenue and Strategic Progress ... (GuruFocus.com)
Aug-08-25 06:30AM	Embecta Corp. Reports Third Quarter Fiscal 2025 Financial Results (GlobeNewswire) +18.53%
06:00AM	embecta Announces Quarterly Cash Dividend (GlobeNewswire)
Jul-24-25 05:00PM	embecta to Report Fiscal Third Quarter 2025 Financial Results (GlobeNewswire)
Jul-13-25 12:27AM	BTIG Lowers PT on Embecta Corp. (EMBC) to $25, Keeps a Buy Rating (Insider Monkey)
Jul-10-25 11:13AM	Mizuho Lowers PT on Embecta Corp. (EMBC) to $13 From $15, Keeps a Neutral Rating (Insider Monkey)
May-27-25 05:00PM	embecta to Participate in Investor Events (GlobeNewswire) +5.09% -6.31%
May-22-25 06:30AM	embecta to Showcase Phased Approach for Value Creation and Present Long Range Financial Plan at 2025 Analyst and Investor Day (GlobeNewswire) -14.97%
May-13-25 10:50AM	Embecta restructures again, outlines tariff costs (MedTech Dive)
May-10-25 05:16AM	Q2 2025 Embecta Corp Earnings Call (Thomson Reuters StreetEvents)
03:03AM	Embecta Corp (EMBC) Q2 2025 Earnings Call Highlights: Strategic Growth Amid Revenue Decline (GuruFocus.com)
May-09-25 12:10PM	Why Is Embecta Stock Falling On Friday? (Benzinga) -10.00%
07:40AM	Embecta Corp. (EMBC) Tops Q2 Earnings Estimates (Zacks)
06:30AM	Embecta Corp. Reports Second Quarter Fiscal 2025 Financial Results (GlobeNewswire)
06:00AM	embecta Announces Quarterly Cash Dividend (GlobeNewswire)
May-08-25 05:15PM	Solventum (SOLV) Tops Q1 Earnings and Revenue Estimates (Zacks) +6.66%
May-07-25 11:35AM	2024 Total Dividend Income And Portfolio Update (Seeking Alpha)
Apr-28-25 07:30AM	Embecta to host Analyst and Investor Day on May 22, 2025 (GlobeNewswire)
Apr-22-25 03:51AM	Beyond the drug: Closing the knowledge gap for injectable diabetes meds (Pharma Voice)
Apr-21-25 05:00PM	embecta to Report Fiscal Second Quarter 2025 Financial Results (GlobeNewswire)
Apr-01-25 08:05AM	Mayo Clinic Proceedings Publishes New Global Insulin Injection Recommendations (GlobeNewswire)
Feb-19-25 03:36PM	Embecta Corp. (EMBC): Among Last Weeks Worst Dividend Stocks (Insider Monkey)
Feb-18-25 05:00PM	embecta to Participate at the J.P. Morgan Global Leveraged Finance Conference (GlobeNewswire)
Feb-07-25 02:09AM	Embecta Corp (EMBC) Q1 2025 Earnings Call Highlights: Navigating Revenue Declines and Strategic ... (GuruFocus.com)
Feb-06-25 07:45AM	Embecta Corp. (EMBC) Tops Q1 Earnings and Revenue Estimates (Zacks)
06:30AM	Embecta Corp. Reports First Quarter Fiscal 2025 Financial Results (GlobeNewswire)
06:00AM	embecta Announces Quarterly Cash Dividend (GlobeNewswire)
Jan-23-25 05:00PM	embecta to Report Fiscal First Quarter 2025 Financial Results (GlobeNewswire)
Dec-19-24 05:00PM	embecta to Participate at the 43rd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-09-24 08:50AM	Here Is Why Bargain Hunters Would Love Fast-paced Mover Embecta Corp. (EMBC) (Zacks)
Dec-06-24 06:00AM	Embecta to cut 125 jobs after ending insulin patch pump (MedTech Dive)
Nov-27-24 06:40AM	Embecta to discontinue insulin patch pump program, initiates restructuring plan (TipRanks) +10.11%
02:02AM	Embecta Corp (EMBC) Q4 2024 Earnings Call Highlights: Strategic Shifts and Financial Performance (GuruFocus.com)
12:26AM	Q4 2024 Embecta Corp Earnings Call (Thomson Reuters StreetEvents)
Nov-26-24 01:15PM	Becton Dickinson Spinoff Embecta Stops Insulin Patch Pump Program, Plans Restructuring, Stock Jumps (Benzinga) +29.77%
07:40AM	Embecta Corp. (EMBC) Tops Q4 Earnings and Revenue Estimates (Zacks)
06:40AM	Embecta discontinues insulin patch pump development (MedTech Dive)
06:30AM	Embecta Corp. Reports Fiscal 2024 Fourth Quarter and Full Year Financial Results; Provides Initial Fiscal Year 2025 Financial Guidance; Discontinues Insulin Patch Pump Program; and Announces Restructuring to Streamline Operations and Reduce Costs (GlobeNewswire)
06:00AM	embecta Announces Quarterly Cash Dividend (GlobeNewswire)
Nov-18-24 10:00AM	Inside a $400 billion bet on the brain-computer interface revolution (Yahoo Finance)
Nov-12-24 05:31PM	UPDATE - embecta to Report Fiscal Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire)
05:00PM	embecta to Report Fiscal Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire)
Nov-07-24 06:30AM	embecta Celebrates National Diabetes Awareness Month by Ringing Nasdaq Closing Bell (GlobeNewswire) -6.37%
Sep-03-24 07:55AM	Embecta gets FDA nod for insulin patch pump (MedTech Dive)
06:30AM	embecta Announces FDA Clearance of its Disposable Patch Pump for Insulin Delivery Informed by the Unique Needs of People with Type 2 Diabetes (GlobeNewswire)
Aug-22-24 05:00PM	embecta to Participate in Investor Events (GlobeNewswire) +6.14%
Aug-12-24 09:35AM	Embecta Corp. (EMBC) Recently Broke Out Above the 20-Day Moving Average (Zacks)
09:30AM	Embecta Corp. (EMBC) Just Overtook the 200-Day Moving Average (Zacks)
Aug-10-24 08:18AM	Embecta Corp. (NASDAQ:EMBC) Q3 2024 Earnings Call Transcript (Insider Monkey)
Aug-09-24 10:52AM	EMBC Stock Earnings: Embecta Beats EPS, Beats Revenue for Q3 2024 (InvestorPlace) +7.32%

Show Previous News

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Morris Milton Mayo	Director	Sep 04 '26	Sale	5.88	6,293	36,971	53,828	Sep 08 05:13 PM
Morris Milton Mayo	Director	Sep 04 '26	Proposed Sale	5.86	6,293	36,891		Sep 04 03:07 PM
Kurdikar Devdatt	President and CEO	Aug 12 '26	Buy	4.70	30,000	140,937	804,919	Aug 13 10:50 AM
Elguicze Jacob	SVP and CFO	Aug 12 '26	Buy	4.67	20,000	93,360	309,139	Aug 13 10:48 AM
Mann Jeffrey Z	Pres, Pharm Svc&Prod Mgmt, CLO	Aug 12 '26	Buy	4.99	20,000	99,800	262,915	Aug 13 10:47 AM
HOMBACH ROBERT J.	Director	Aug 12 '26	Buy	4.97	45,000	223,848	109,587	Aug 13 10:45 AM

Embecta Corp. engages in the provision of medical devices used in the treatment of diabetes. Its products include pen needles, syringes, and safety devices complemented by a digital application. The company was founded in 1924 and is headquartered in Parsippany, NJ.

PresidentMr. Devdatt Kurdikar Ph.D.

Senior VP & CFOMr. Jacob P. Elguicze

Senior VPMr. Jeffrey Z. Mann

Senior VP & Chief Human Resources OfficerMs. Jean M. Casner

Senior Vice President of Global Manufacturing & Supply ChainMr. Shaun Curtis

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

EMBC

Embecta Corp

Upgrade your Finviz experience